Produkty 516-37-0

CAS 516-37-0 występuje w naszej ofercie pod nazwami: Cerevisterol, Cerevisterol, 99.88%, Cerevisterol, 98+%. Oferty producentów: GLPBio, Biosynth, MedChemExpress, Chemat. Dostępne opakowania: 1mg, 5mg, 10mg, 5 mg, 1 mg, 10 mg, 25mg.

Cerevisterol
GLPBio, Biosynth
  • opakowanie: 1mg, 5mg, 10mg
  • Warianty: 5
od 1172,74
Zobacz produkt
Cerevisterol, 99.88%
MedChemExpress
  • opakowanie: 5 mg, 1 mg, 10 mg
  • Warianty: 3
od 983,78
Zobacz produkt
Cerevisterol, 98+%
Chemat
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 4
od 966,80
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,5R,6R,9S,10R,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,2,3,4,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,5,6-triol (CAS 516-37-0) to związek chemiczny o wzorze sumarycznym C28H46O3 i masie molowej 430.7 g/mol. Nazwa systematyczna IUPAC: (3S,5R,6R,9S,10R,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,2,3,4,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,5,6-triol. InChIKey: ARXHRTZAVQOQEU-BRVLHLJYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC28H46O3
Masa molowa430.7 g/mol
Nazwa IUPAC(3S,5R,6R,9S,10R,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,2,3,4,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,5,6-triol
InChIKeyARXHRTZAVQOQEU-BRVLHLJYSA-N
SMILESC[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=C[C@H]([C@@]4([C@@]3(CC[C@@H](C4)O)C)O)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Cerevisterol, Cerevisterin, Ergosta-7,22-diene-3,5,6-triol, (3beta,5alpha,6beta,22E)-, 5alpha-Ergosta-7,22-diene-3beta,5,6-triol, Ergosta-7,22-diene-3beta,5alpha,6beta-triol, (22E)-ergosta-7,22-diene-3beta,5alpha,6beta-triol, Ergosta-7, 22-dien-3beta,5alpha,6beta-triol, Ergosta-7,22E-diene-3beta,5alpha,6beta-triol, 5alpha-Ergosta-7,22-diene-3beta,5,6beta-triol, 3beta,5alpha,6beta-trihydroxyl-ergosta-7,22-diene
Izomery (ten sam wzór sumaryczny)
trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-7-hydroxy-7-methyloctan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol C28H46O3
[(5S,8R,9R,10S,13S,14S)-13-methyl-3-oxo-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] decanoate C28H46O3
5-[(Z)-octadec-9-enoxy]-2-phenyl-1,3-dioxane C28H46O3
trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2S)-6-hydroxy-6-methyloctan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol C28H46O3
2-[(3S,8S,9S,10S,13R,14S,17R)-3-hydroxy-13-methyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]acetic acid C28H46O3
(3S,4S,5S,9R,10S,13R,14R,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-4-carboxylic acid C28H46O3
(1R,3aR,4R,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-4-[(1R,2Z)-1-hydroxy-2-[(5S)-5-hydroxy-2-methylidenecyclohexylidene]ethyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ol C28H46O3
(1S,2R,5R,6R,9R,10R,13S,15S)-5-[(2R,5S)-5,6-dimethylheptan-2-yl]-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.01,9.02,6.010,15]nonadec-18-en-13-ol C28H46O3
(3S,7S,8S,9S,10R,13S,14S,16S,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7,16-triol C28H46O3